Asherman syndrome is a condition where scar tissue forms inside the uterus and can cause lighter periods, no periods, pelvic discomfort, or trouble getting pregnant. It often follows uterine surgery or infection and can be long‑lasting without treatment. People with Asherman syndrome are usually in their reproductive years, and early symptoms of Asherman syndrome may include periods that suddenly become very light or stop after a dilation and curettage. It does not affect life expectancy, but it can affect fertility and pregnancy outcomes. Treatment for Asherman syndrome usually involves hysteroscopic surgery to remove scar tissue, followed by medications and follow‑up to help the uterine lining heal.
Overview
Asherman syndromeSymptoms
Asherman syndrome can cause very light or absent periods, cramps with little bleeding, and pelvic discomfort. Many notice trouble getting pregnant or repeated miscarriages; early symptoms of Asherman syndrome may be shorter cycles or new severe pain.
Outlook and prognosis
Most people with Asherman syndrome improve with careful treatment to reopen and heal the uterus, especially when scarring is mild to moderate. Recovery can take time, and some need more than one procedure. Menstrual flow and fertility often return, though risks like miscarriage or placenta problems can be higher in future pregnancies.
Causes and risk factors
Asherman syndrome usually follows uterine instrumentation or surgery—especially dilation and curettage after miscarriage, postpartum procedures, cesarean, myomectomy, or endometrial ablation. Infection (notably genital tuberculosis), pelvic radiation, and severe postpartum hemorrhage increase risk. There’s no known inherited or lifestyle-driven cause.
Genetic influences
Genetics play a limited role in Asherman syndrome. Most cases stem from uterine injury after procedures or infection, not inherited changes. Rarely, gene variants may influence scarring tendency, but routine genetic testing isn’t recommended.
Diagnosis
Diagnosis of Asherman syndrome starts with your history—menstrual changes, pregnancy losses, and prior uterine procedures. Ultrasound, saline sonohysterography, or hysterosalpingography can suggest scarring. Hysteroscopy confirms the diagnosis and often allows treatment.
Treatment and drugs
Asherman syndrome is managed by gently releasing scar tissue inside the uterus, usually with hysteroscopic surgery, to reopen and reshape the cavity. Doctors often place a temporary spacer and prescribe estrogen to help the lining heal. Follow-up imaging and, when needed, repeat hysteroscopy support recovery and future fertility.
Symptoms
Asherman syndrome can affect periods, fertility, and how the uterus feels month to month. Early symptoms of Asherman syndrome often include lighter periods or no bleeding after a gynecologic procedure or childbirth. Some notice pelvic cramping around the time a period should come, with little or no flow. Symptoms vary from person to person and can change over time.
Periods may become very light or stop. This often happens after treatment for a miscarriage, fibroids, or an infection in the uterus. You might still feel monthly bloating or mood changes, even with little bleeding.
Strong cramps can show up when a period is due, but little or no blood comes out. Pressure from trapped blood or scarring can cause this pain. It may come in waves each month.
It may be harder to conceive. In Asherman syndrome, scar tissue can make it difficult for an embryo to implant. Some people need treatment to gently reopen the cavity before trying again.
A pregnancy may start but end early. When Asherman syndrome is present, scar tissue can limit space or blood supply for a growing pregnancy. Your care team may investigate for scarring after repeated losses.
How people usually first notice Asherman syndrome?
People usually first notice Asherman syndrome after a period stops or becomes very light following a uterine procedure, such as dilation and curettage (D&C) after miscarriage, childbirth, or abortion. For many, the clue is new cramping or pelvic pain at the time a period should come, difficulty getting pregnant, or repeated miscarriages after previously regular cycles. Doctors often suspect it when periods change suddenly after uterine surgery or infection and confirm it with imaging or hysteroscopy.
Types of Asherman syndrome
Asherman syndrome affects the lining of the uterus, creating scar tissue that can change periods, fertility, and pregnancy outcomes. Doctors describe different types based on where the scar tissue sits and how much of the cavity it involves, which helps predict symptoms and guide treatment. Symptoms don’t always look the same for everyone. When people ask about types of Asherman syndrome, they’re usually referring to the extent and location of adhesions rather than completely different diseases.
Mild adhesions
Thin, filmy bands involve a small part of the uterine cavity. Periods may be lighter but still present, and cramping may be mild. Fertility can be affected yet often improves after gentle removal.
Moderate adhesions
Thicker bands cover a larger area or bridge parts of the cavity. Periods may become very light or irregular, with more noticeable cramps. Conception is possible but miscarriage risk may rise until adhesions are treated.
Severe adhesions
Dense scarring can partially or nearly completely close the cavity. Periods may be very scant or stop, and pelvic pain can increase. Surgery often requires multiple steps and careful follow-up to restore the space.
Fundal scarring
Adhesions mainly affect the top of the uterus where pregnancies usually implant. Periods may be lighter, but the bigger concern is implantation problems. Treating this area can improve chances of a healthy implantation.
Cervical obstruction
Scar tissue narrows or blocks the cervical canal. You might notice very light periods with significant cramps from trapped flow, or difficulty with procedures like IUD placement. Opening the canal can relieve pain and help fertility.
Lateral wall bands
Bands tether the side walls together, changing the shape of the cavity. Periods may be irregular, and some feel crampy pain midcycle. Hysteroscopic release can restore the normal contour.
Global involvement
Adhesions spread across most of the cavity rather than one spot. Symptoms can include absent periods and infertility, and procedures like embryo transfer may be difficult. This is one of the more complex types of Asherman syndrome to repair.
Post-infection pattern
Scarring follows uterine infection after events like miscarriage or delivery. Period changes and pelvic discomfort may appear weeks to months later. Early evaluation for types of Asherman syndrome can help limit long-term scarring.
What genetics can tell you about symptoms
Some people with Asherman syndrome have milder periods or no periods after uterine scarring genes and healing responses create adhesions that block or thin the uterine lining. Variants affecting tissue repair or inflammation can raise risk of pelvic pain, miscarriage, and infertility.
Causes and risk factors
Asherman syndrome most often follows scar tissue inside the uterus after a procedure or infection. Key risk factors for Asherman syndrome include dilation and curettage after miscarriage or abortion, treatment for a retained placenta after birth, and repeated uterine surgeries. Uterine infections, including genital tuberculosis in some regions, can also cause scar tissue. Some risks are modifiable (things you can change), others are non-modifiable (things you can’t). It is not an inherited condition, and lifestyle choices have a smaller impact than medical and infection-related factors.
Environmental and biological risk factors
Asherman syndrome happens when scar tissue forms inside the uterus, often after a procedure or infection. If you’re recovering from a miscarriage, birth, or uterine surgery, it’s helpful to know the environmental and biological risk factors for Asherman syndrome. Doctors often group risks into internal (biological) and external (environmental). Below are common situations that can raise the chance of adhesions forming.
Dilation and curettage (D&C) performed after a miscarriage can remove healthy lining along with pregnancy tissue. This makes adhesions more likely to form, increasing the risk of Asherman syndrome. The risk is higher if infection is present at the time.
After birth, procedures to remove a retained placenta can injure the newly healing uterine surface. Adhesions can develop where the lining was stripped or inflamed. Risk is highest in the first weeks after delivery.
Multiple D&Cs or repeat procedures after pregnancy loss add up in their impact. Each pass can create small injuries that scar together over time and lead to Asherman syndrome. Risk rises with the number and extent of procedures.
Ablation intentionally destroys the uterine lining to reduce heavy bleeding. In some people, healing creates broad scarring and bridges across the cavity, causing Asherman syndrome. Adhesions may be more extensive when ablation is combined with prior curettage.
Genetic risk factors
There is no clear inherited cause for Asherman syndrome. Science continues to uncover how these elements interact. When people ask about genetic risk factors for Asherman syndrome, current research points to little or no direct genetic influence.
No confirmed genes: Research has not identified specific gene changes that directly cause Asherman syndrome. Most cases do not show a repeating pattern within families.
Low heritability signal: Family reports have not shown consistent clustering of Asherman syndrome across generations. This makes a strong inherited risk unlikely.
Fibrosis genes unclear: Variants in wound-healing and scarring pathways are being studied. So far, no reliable link to Asherman syndrome has been proven.
Population patterns absent: Studies have not validated ethnic or population-based genetic associations. Findings to date do not point to a specific inherited susceptibility.
Congenital uterine traits: Some people have genetic differences in uterine development. On their own, these have not been shown to raise the risk of intrauterine adhesions.
Lifestyle risk factors
While medical procedures and infections are the main drivers, several lifestyle risk factors for Asherman syndrome relate to care choices and behaviors that influence uterine injury or healing. Safer sexual health, informed procedure choices, and diligent aftercare can lower risk. Nutrition and tobacco use may also affect how the endometrium repairs after any uterine trauma.
Seeking care from untrained or unregulated providers raises the chance of excessive uterine scraping and scarring. Choosing qualified, evidence-based care lowers intrauterine adhesion risk.
Opting for multiple dilation and curettage procedures when medical management is suitable increases cumulative endometrial injury. Discussing non-surgical options can reduce adhesion formation.
Unprotected sex and skipped testing increase the risk of endometritis, which can scar the uterine lining. Consistent condom use and regular screening lower infection-related adhesion risk.
Skipping follow-up or not taking prescribed antibiotics after miscarriage care or delivery can allow infection and scarring to develop. Adhering to aftercare instructions helps protect the endometrium.
Risk prevention
Asherman syndrome often develops after procedures or infections that irritate the lining of the uterus, so prevention focuses on gentle care and timely treatment. Choosing less invasive options when possible and using careful techniques during necessary procedures can lower risk. Knowing warning signs—like unusually light periods after a uterine procedure—can prompt early care before scarring worsens. Talk to your doctor about which preventive steps are right for you.
Ask whether medical management for miscarriage or termination is an option instead of scraping the uterus. When a procedure is needed, using the smallest instruments and avoiding repeated curettage can help protect the uterine lining.
Procedures done with ultrasound or hysteroscopy (a tiny camera) help the clinician see what they’re doing. This reduces the chance of accidental injury and scarring that can lead to Asherman syndrome.
If you need uterine surgery, choose a clinician and center that do these procedures often. Skill and experience are linked with fewer complications and less risk of adhesions.
Treat postpartum or post-procedure fevers, pelvic pain, or foul discharge quickly. Fast treatment of endometritis or sexually transmitted infections may prevent scarring inside the uterus.
Transmission
Asherman syndrome is not contagious and cannot be transferred between people. Questions about how Asherman syndrome is transmitted come up often, but it isn’t passed by sex, kissing, sharing a home, or from parent to child. Instead, it usually develops when the lining of the uterus scars after a procedure such as a D&C (dilation and curettage) or other uterine surgery; more rarely, a severe uterine infection after childbirth or, in some regions, tuberculosis affecting the uterus can lead to scarring. There’s no risk of “catching” Asherman syndrome from someone else, and it does not spread during pregnancy or to a partner.
When to test your genes
Asherman syndrome is usually acquired after uterine surgery or infection, so genetic testing isn’t part of diagnosis or care. Consider gene testing only if your history suggests another inherited condition affecting fertility or miscarriage risk. Most people benefit more from imaging (e.g., hysteroscopy) and individualized surgical and reproductive planning.
Diagnosis
People with Asherman syndrome often notice lighter periods, no periods, or trouble getting pregnant after a miscarriage, delivery, or uterine procedure. Your provider uses a stepwise approach that starts with your story and moves to targeted exams and imaging to make the diagnosis of Asherman syndrome. Tests may feel repetitive, but each one helps rule out different causes. Understanding how Asherman syndrome is diagnosed can also guide treatment planning and timelines, especially if you’re hoping to conceive.
Your doctor asks about periods, pregnancy losses, prior D&C or other uterine procedures, infections, and pelvic pain. These clues often point toward scarring inside the uterus.
A gentle exam checks for cervical narrowing and rules out other causes of bleeding changes. The exam also helps guide which tests come next.
A urine or blood test checks for pregnancy. This matters because testing and symptoms are interpreted differently if you could be pregnant.
Blood tests may look at thyroid, prolactin, and ovarian hormones to exclude other causes of irregular or absent periods. Normal results make uterine causes like adhesions more likely.
Stages of Asherman syndrome
Asherman syndrome does not have defined progression stages. It varies based on how much and where scar tissue forms inside the uterus, and it doesn’t always worsen over time—many people find symptoms remain fairly steady unless treated. If you’re noticing early symptoms of Asherman syndrome—such as lighter or absent periods after a uterine procedure—your doctor will review your history and exam, and may use imaging like a saline ultrasound or X‑ray dye study, or look directly inside the uterus with a thin camera (hysteroscopy). Different tests may be suggested to help confirm the diagnosis and map where scar tissue is located.
Outlook and prognosis
Many people ask, “What does this mean for my future?”, especially right after being told they have Asherman syndrome. For many, treatment with careful hysteroscopic surgery can reopen the uterus and improve periods, reduce pain, and restore fertility. Periods may return gradually over a few months; some people notice lighter bleeding at first, while for others flow normalizes more quickly. When thinking about the future, it helps to know that repeat procedures are sometimes needed because scar tissue can come back, particularly after severe adhesions.
Doctors call this the prognosis—a medical word for likely outcomes. Pregnancy is possible after treatment for Asherman syndrome, but chances vary with how extensive the adhesions were and how well the uterine lining recovers. Risks during pregnancy can be higher, including miscarriage, placenta attaching too deeply, preterm birth, or the need for a cesarean; your care team will usually monitor more closely. Early care can make a real difference, because treating adhesions sooner—before they become dense or affect most of the cavity—tends to improve menstrual recovery and conception rates.
Life expectancy is not shortened by Asherman syndrome itself, and mortality from the condition is extremely rare in high-resource settings. The biggest day-to-day impact is on periods, pain, and fertility, and on navigating pregnancy safely if you conceive. Knowing what to expect can ease some of the worry, and it’s reasonable to ask about early symptoms of Asherman syndrome returning—such as scant periods or new cramping—so they can be checked promptly. Talk with your doctor about what your personal outlook might look like, including your goals for periods, pain control, and future pregnancy, and how often follow-up is recommended after treatment.
Long-term effects
Asherman syndrome can have lasting effects on periods, fertility, and future pregnancies. Long-term effects vary widely, from light or absent periods to trouble conceiving or carrying a pregnancy. Many people do well after treatment, but adhesions sometimes return, so outlook often depends on how severe the scarring is. The long-term picture is shaped by the cause, the amount of scar tissue, and any other uterine conditions.
Periods may be very light or stop, and cramps can occur with little or no bleeding. Some notice spotting between expected cycles; early symptoms of Asherman syndrome often look like lighter periods after a procedure.
Scarring can lower the chance of natural conception by narrowing or blocking parts of the uterus. A thinner or irregular uterine lining may also make implantation harder.
The risk of miscarriage is higher when the uterine lining is scarred or patchy. For some, this includes repeated first‑trimester losses.
Future pregnancies carry higher chances of placenta previa or the placenta growing too deeply (placenta accreta). These problems raise the risk of bleeding, preterm birth, and delivery complications.
How is it to live with Asherman syndrome?
Living with Asherman syndrome often means navigating unpredictable periods or none at all, pelvic discomfort, and the emotional weight of fertility challenges after a miscarriage, delivery, or uterine procedure. Daily life can revolve around appointments, imaging, and procedures to restore the uterine lining, with stretches of waiting that test patience and hope. Partners, family, and close friends may feel the ripple effects—sharing worry, adjusting plans, and learning how to be supportive—while many find relief in clear information, a stepwise care plan, and connecting with others who’ve been through it.
Treatment and drugs
Treatment for Asherman syndrome focuses on safely opening the scarred areas inside the uterus and helping the lining heal well afterward. The main procedure is hysteroscopic adhesiolysis, where a doctor uses a thin camera and small instruments through the cervix to gently cut scar tissue; this is usually done under anesthesia and avoids external incisions. After the uterus is opened, doctors often place a temporary device (such as a small balloon) and prescribe medicines that support regrowth of the uterine lining, like estrogen, sometimes with antibiotics to reduce infection risk. Not every treatment works the same way for every person, and some people need more than one procedure, especially if the adhesions are dense or recur. Your doctor may suggest follow-up imaging or a second-look hysteroscopy to confirm healing and guide plans for periods, pain relief, or future pregnancy.
Non-drug treatment
For many, the day-to-day impact shows up as lighter periods, cramps without flow, or difficulty getting pregnant; when this happens with Asherman syndrome, care focuses on safely reopening the uterus and keeping it from scarring again. If you’re navigating early symptoms of Asherman syndrome, non-drug treatments aim to restore normal anatomy and improve comfort and fertility. Non-drug treatments often lay the foundation for recovery and future family-building plans. Your care team will tailor choices to how much scarring is present and your goals for pregnancy.
A thin scope is passed through the cervix to see and gently release scar bands under direct vision. This outpatient procedure often helps periods return and can improve fertility.
Real-time ultrasound can guide the hysteroscope during scar removal. This added imaging helps map the uterine cavity and lowers the risk of creating a false passage or perforation.
A small soft balloon or stent may be placed for several days to keep the uterine walls from sticking back together. This mechanical spacer supports healing and lowers the chance of new adhesions.
Surgeons may apply a temporary gel or thin film that acts like a physical shield between healing surfaces. These barriers reduce friction so tissues are less likely to reattach.
Your genes may have an impact on how drugs work for you
Medications used around procedures for Asherman syndrome—like pain control, antibiotics, or hormones to prepare or heal the uterine lining—can work differently based on your genes, affecting dose needs and side‑effect risk. Pharmacogenetic testing sometimes helps tailor choices, but isn’t routine.
Pharmacological treatments
Medicine for Asherman syndrome is usually used around a planned hysteroscopic procedure to support healing, manage pain, and lower infection risk. Estrogen-based therapy is commonly given after adhesions are released to help the uterine lining regrow, sometimes followed by a short course of progesterone. Antibiotics may be used briefly if infection is suspected or as peri‑procedure prevention, and pain relievers can ease cramping. Doctors adjust treatment plans regularly to fit your goals and recovery, and your team may discuss postoperative estrogen therapy for Asherman syndrome if you’re healing after surgery.
Estradiol or conjugated estrogens help the uterine lining regrow after surgery. Typical choices include oral estradiol or a transdermal estradiol patch for several weeks.
Medroxyprogesterone acetate or micronized progesterone is often added for 10–14 days after estrogen. This helps trigger a withdrawal bleed and organizes the new lining.
Low‑dose combined oral contraceptives (ethinyl estradiol with levonorgestrel or norethindrone) can regulate cycles during healing. They can also provide contraception if pregnancy is not advised immediately after Asherman syndrome treatment.
Ibuprofen or naproxen can reduce cramping and post‑procedure discomfort. These also help with period pain when menstruation returns after Asherman syndrome care.
Genetic influences
Most people who develop Asherman syndrome do so after a clear event—such as a dilation and curettage (D&C), cesarean or other uterine surgery, or a uterine infection—rather than because of inherited risk. It’s natural to ask whether family history plays a role. So far, researchers have not found a specific gene or inherited pattern that directly causes Asherman syndrome, and having a relative with it rarely changes your personal risk. Some people may have natural differences in wound healing and scar formation, which could be influenced by genes, but current evidence is limited and indirect. Because of this, genetic testing is not routinely recommended for Asherman syndrome, and doctors usually focus on your medical history, especially any procedures or infections affecting the uterus. If you’re concerned about genetic causes of Asherman syndrome, a conversation with a gynecologist or a genetic counselor can help review your family and surgical history and guide next steps.
Is Asherman syndrome genetic?
Genetics play a limited role in Asherman syndrome. Most cases stem from uterine injury after procedures or infection, not inherited changes. Rarely, gene variants may influence scarring tendency, but routine genetic testing isn’t recommended.
Pharmacogenetics—how genetics influence drug effects
After hysteroscopic treatment to remove scar tissue, many are prescribed estrogen to help the lining heal; inherited clotting risk can influence whether estrogen is used and in what form. If you carry a common clotting change such as Factor V Leiden or the prothrombin gene variant, your team may consider a lower dose, a patch instead of pills, or alternatives to reduce blood-clot risk. Pain control and anesthesia for the procedure can also be shaped by genes that affect drug breakdown; people who activate codeine or tramadol too slowly may get little relief, while very fast activators may have stronger side effects. Share any family history of malignant hyperthermia or difficulty with anesthesia, because these inherited risks can guide the choice of anesthetic drugs and monitoring. Antibiotics or other peri-procedure medicines can rarely cause gene-linked reactions, so let your clinicians know about any past severe drug reactions. Genetics is only one factor; surgical technique, the extent of adhesions, and your overall health usually have a bigger impact on recovery and fertility in Asherman syndrome. At this time, pharmacogenetic testing for Asherman syndrome isn’t routine, but in select situations your care team may use genetic information to tailor pain medicine or estrogen safety.
Interactions with other conditions
People living with Asherman syndrome often also face other conditions that affect periods and fertility, which can blur what’s causing which symptom day to day. Doctors call it a “comorbidity” when two conditions occur together. Early symptoms of Asherman syndrome, like lighter or infrequent periods, can overlap with thyroid problems or polycystic ovary syndrome (PCOS), so it’s common for evaluations to look at more than one cause at once. In some regions, genital tuberculosis or pelvic infections can both trigger and coexist with Asherman syndrome, and treating the infection is essential before or alongside uterine scar treatment. Gynecologic conditions such as uterine fibroids, endometriosis, or adenomyosis may be present too, adding pelvic pain or irregular bleeding that can mask the scarring’s effects. During future pregnancies, Asherman syndrome is linked with a higher chance of miscarriage, placenta previa or placenta accreta spectrum, and retained placenta, so obstetric care is usually more closely monitored. Because these interactions vary widely, many benefit from coordinated care among a fertility specialist, an obstetrician familiar with high‑risk pregnancies, and, when infection is suspected, an infectious disease specialist.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described delayed or absent periods and difficulty becoming pregnant after difficult births or infections. Midwives wrote about “sealed” wombs after miscarriages or procedures. Families shared stories of cycles that never returned after a postpartum infection. These everyday observations captured what we now group as Asherman syndrome.
First described in the medical literature as scarring inside the uterus causing missed periods and infertility, the condition took shape in the late 19th and early 20th centuries. Early doctors mainly recognized it after curettage (a procedure to remove tissue after miscarriage or birth). At the time, diagnosis relied on symptoms and exam alone; the internal scarring itself was hidden from view.
From these first observations, surgeons began to link specific events—especially repeated uterine procedures or infections after childbirth—to later menstrual changes. Before antibiotics and safer surgical techniques, postpartum infections were more common, and reports of menstrual flow becoming very light or stopping entirely appeared across Europe and the United States. Even so, not every description was complete, and many living with Asherman syndrome went undiagnosed or were told stress or “hormones” were to blame.
As medical science evolved, imaging offered glimpses into the uterine cavity. X‑ray dye studies showed irregular shapes where scar tissue tethered the walls together. The major shift came with hysteroscopy in the late 20th century—a small camera placed through the cervix allowed doctors to see adhesions directly, grade their extent, and treat them through the same scope. This turned a condition once inferred from symptoms into one that could be confirmed and, in many cases, repaired.
With each decade, understanding deepened. Researchers recognized that Asherman syndrome varies: some people have thin bands of scar with light periods; others have extensive adhesions with no bleeding and cramping when flow cannot exit. Reports also highlighted broader causes, including tuberculosis of the uterus in some regions and retained tissue after miscarriage or termination. Surgical methods gradually shifted toward gentler techniques, ultrasound guidance, and preventive measures to lower the risk of new scarring.
In recent decades, awareness has grown alongside fertility care. Specialists refined strategies to reduce recurrence after treatment—using estrogen to help the lining regrow, placing temporary devices to keep the walls apart, and scheduling careful follow-up. Outcomes improved, though the risk of return depends on how severe the scarring was to start.
Looking back helps explain why early symptoms of Asherman syndrome were missed or misunderstood. What began as scattered case descriptions matured into a clear pattern supported by modern tools. Today’s approach—early recognition after a high‑risk event, direct visualization, and gentle repair—stands on that history, with ongoing research focused on preventing scarring in the first place.